Charlotta Movitz

1.1k total citations
25 papers, 767 citations indexed

About

Charlotta Movitz is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Charlotta Movitz has authored 25 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in Charlotta Movitz's work include S100 Proteins and Annexins (13 papers), Immune Response and Inflammation (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Charlotta Movitz is often cited by papers focused on S100 Proteins and Annexins (13 papers), Immune Response and Inflammation (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Charlotta Movitz collaborates with scholars based in Sweden, United States and France. Charlotta Movitz's co-authors include Cláes Dahlgren, Anna Karlsson, Johan Bylund, Jennie Karlsson, Huamei Fu, Kristoffer Hellstrand, Kelly L. Brown, Carola Sjölin, Lena Björkman and Staffan Nilsson and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Charlotta Movitz

23 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotta Movitz Sweden 17 450 403 95 83 83 25 767
P M Rosoff United States 15 430 1.0× 249 0.6× 79 0.8× 61 0.7× 67 0.8× 20 794
André Holdfeldt Sweden 16 486 1.1× 284 0.7× 68 0.7× 60 0.7× 54 0.7× 32 601
Gillian M. Tannahill United Kingdom 12 335 0.7× 319 0.8× 56 0.6× 66 0.8× 16 0.2× 15 720
Jasmine H.P. Chan Singapore 8 540 1.2× 204 0.5× 212 2.2× 72 0.9× 34 0.4× 9 863
Kaiyuan Wu China 16 373 0.8× 90 0.2× 110 1.2× 71 0.9× 26 0.3× 39 627
Éric Krump Canada 15 494 1.1× 326 0.8× 224 2.4× 67 0.8× 20 0.2× 23 966
Andrew T. Holdbrooks United States 9 538 1.2× 655 1.6× 69 0.7× 116 1.4× 13 0.2× 12 1.2k
Jae Woong Shim South Korea 17 396 0.9× 181 0.4× 55 0.6× 78 0.9× 59 0.7× 25 587
Laura Rocco Carpenter United States 11 644 1.4× 185 0.5× 95 1.0× 71 0.9× 20 0.2× 13 1.1k
Masakatsu Nanamori United States 12 532 1.2× 170 0.4× 51 0.5× 35 0.4× 61 0.7× 14 700

Countries citing papers authored by Charlotta Movitz

Since Specialization
Citations

This map shows the geographic impact of Charlotta Movitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotta Movitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotta Movitz more than expected).

Fields of papers citing papers by Charlotta Movitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotta Movitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotta Movitz. The network helps show where Charlotta Movitz may publish in the future.

Co-authorship network of co-authors of Charlotta Movitz

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotta Movitz. A scholar is included among the top collaborators of Charlotta Movitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotta Movitz. Charlotta Movitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Singh, Dave, Fernando J. Martínez, John R. Hurst, et al.. (2024). Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS). American Journal of Respiratory and Critical Care Medicine. 211(2). 205–214. 10 indexed citations
4.
Nilsson, Malin S., Anna Rydström, Johan Aurelius, et al.. (2017). Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy. Cancer Immunology Immunotherapy. 66(11). 1473–1484. 44 indexed citations
5.
Akhiani, Ali A., Johan Aurelius, Charlotta Movitz, et al.. (2014). Role of the ERK Pathway for Oxidant-Induced Parthanatos in Human Lymphocytes. PLoS ONE. 9(2). e89646–e89646. 36 indexed citations
6.
Björkman, Lena, Karin Christenson, Mikael Alsterholm, et al.. (2013). A simple skin blister technique for the study of in vivo transmigration of human leukocytes. Journal of Immunological Methods. 393(1-2). 8–17. 18 indexed citations
7.
Bylund, Johan, Kelly L. Brown, Charlotta Movitz, Cláes Dahlgren, & Anna Karlsson. (2010). Intracellular generation of superoxide by the phagocyte NADPH oxidase: How, where, and what for?. Free Radical Biology and Medicine. 49(12). 1834–1845. 154 indexed citations
8.
Movitz, Charlotta, Lars Brive, Kristoffer Hellstrand, Marie‐Josèphe Rabiet, & Cláes Dahlgren. (2010). The Annexin I Sequence Gln9-Ala10-Trp11-Phe12 Is a Core Structure for Interaction with the Formyl Peptide Receptor 1. Journal of Biological Chemistry. 285(19). 14338–14345. 30 indexed citations
9.
Karlsson, Jennie, Johan Bylund, Charlotta Movitz, et al.. (2009). A methodological approach to studies of desensitization of the formyl peptide receptor: Role of the read out system, reactive oxygen species and the specific agonist used to trigger neutrophils. Journal of Immunological Methods. 352(1-2). 45–53. 18 indexed citations
10.
Movitz, Charlotta, et al.. (2009). Oxygen radical production in leukocytes and disease severity in multiple sclerosis. Journal of Neuroimmunology. 213(1-2). 131–134. 37 indexed citations
11.
Dahlberg, Maria, Cláes Dahlgren, Kristoffer Hellstrand, & Charlotta Movitz. (2008). A new chemiluminescence paradox: selective inhibition of isoluminol‐amplified activity in phagocytes by peptides from annexin AI. Luminescence. 23(3). 139–143. 4 indexed citations
12.
Movitz, Charlotta, et al.. (2006). Lipid raft proteome of the human neutrophil azurophil granule. PROTEOMICS. 7(2). 194–205. 32 indexed citations
13.
Fu, Huamei, Jennie Karlsson, Johan Bylund, et al.. (2005). Ligand recognition and activation of formyl peptide receptors in neutrophils. Journal of Leukocyte Biology. 79(2). 247–256. 135 indexed citations
15.
Mosgoeller, Wilhelm, Charlotta Movitz, Jörgen Bergström, et al.. (2002). The presence of stomatin in detergent-insoluble domains of neutrophil granule membranes. Journal of Leukocyte Biology. 72(5). 970–977. 21 indexed citations
16.
Movitz, Charlotta & Cláes Dahlgren. (2001). QUANTIFICATION OF ANNEXIN I IN SUBCELLULAR FRACTIONS OF HUMAN NEUTROPHILS REVEALS AN EXCLUSIVE CYTOSOLIC LOCALISATION. Cell Biology International. 25(10). 963–969. 7 indexed citations
17.
Movitz, Charlotta & Claes Dahlgren. (2000). Endogenous cleavage of annexin I generates a truncated protein with a reduced calcium requirement for binding to neutrophil secretory vesicles and plasma membrane. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1468(1-2). 231–238. 9 indexed citations
18.
Movitz, Charlotta, Carola Sjölin, & Cláes Dahlgren. (1999). Cleavage of annexin I in human neutrophils is mediated by a membrane-localized metalloprotease. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1416(1-2). 101–108. 21 indexed citations
19.
20.
Sjölin, Carola, Charlotta Movitz, Helen Lundqvist, & Cláes Dahlgren. (1997). Translocation of annexin XI to neutrophil subcellular organelles. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1326(1). 149–156. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026